Bristol-Myers Squibb Up 1% on New Drug Applications

Recently, Bristol-Myers Squibb (BMY)  submitted new drug applications to the U.S. Food and Drug Administration (FDA).

 

 

Related posts

*

*

Top

Warren Buffett's Best Picks

Warren Buffett's these stock picks will crush the market over the next 12 months. Get our report FREE by becoming a member now